Serum Folate Correlates with Severity of Guillain-Barré Syndrome and Predicts Disease Progression
Table 2
Characteristics of GBS patients with and without folate .
Group
GBS with folate deficiency (n = 21)
GBS without folate deficiency (n = 91)
p
Demographics
Age, mean (SD)
53.48 (17.20)
51.95 (12.73)
0.70
Female
9.5% (2/21)
50.5% (46/91)
0.001
Weakness at nadir, median (IQR)
GBS disability score
3 (2-4)
4 (3-4)
0.61
MRC score
48 (28.5-50)
40 (24-48)
0.30
Disease course, median (IQR)
Hospital days
15 (12-19)
13 (11-18)
0.55
Ventilator days (n = 10)
13 (8-13)
27 (14-101)
0.27
Progression duration, d
13 (7-18)
6 (4-11)
0.006
MRC, Medical Research Council. are presented as percentage of patients unless otherwise indicated. All items are shown for 112 patients unless otherwise specified.
